Top Analyst Reports For Philip Morris, ConocoPhillips & Alibaba
Zacks Investment Research | May 10, 2018 10:53PM ET
Friday, May 11, 2018
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Philip Morris (PM), ConocoPhillips (NYSE:COP) and Alibaba (NYSE:BABA). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Philip Morris’ shares have underperformed the Zacks Tobacco industry over the last six months (-19.8% vs. -17.5%) due to persistent declines in cigarette volumes, stemming from consumers’ rising health consciousness and stringent government regulations on tobacco products. These factors, which have been marring cigarette industry volumes for a while now, led to a 5.3% drop in Phillip Morris’ cigarette volumes during first-quarter 2018.
Nevertheless, solid revenues from the reduced risk products (RRPs) category are a major driver for Phillip Morris. The company is making constant efforts to expand in the space. In fact, the top and the bottom line grew year over year during the first-quarter, courtesy of favorable cigarette pricing and solid RRP performance, with the latter being driven by consistent success of IQOS. Management uplifted its earnings view for 2018, as it expects recent tax reforms to aid bottom-line growth.
(You can ).
Shares of ConocoPhillips are up +47.6% over the last year, outperforming the Zacks U.S. Integrated Oil industry, which has gained +33.6% over the same period. The Zacks analyst likes the company’s initiative to divest non-core assets as the explorer could divert the proceeds toward oil-rich Eagle Ford and Bakken shale plays.
Significant opportunities are left for ConocoPhillips in the Eagle Ford where it owns 3,400 undrilled locations that could lend access to almost 2.3 billion barrels of oil equivalent estimated potential reserves. The company recently reported strong first-quarter 2018 results, courtesy of higher oil and natural gas price realizations.
However, we are cautious about ConocoPhillips’ expectations of a rise in production and operating expenses. Moreover, ConocoPhillips’ long-term debt is more than double its cash balance, which is a concern.
(You can ).
Alibaba’s shares have outperformed the Zacks Electronic Commerce industry over the last year, gaining +62.8% vs. +48.6%. The company's fiscal fourth quarter results were driven by strong momentum in the company’s core e-commerce business, New Retail strategy and expanding cloud business.
Get The News You Want
Its recent investment in Lazada will expand its presence in Asia. The Zacks analyst likes the company's solid growth in the company’s core e-commerce business, strong growth in metrics, expanding cloud business and international strength.
Other drivers include strong mobile strength and its continued efforts to develop new products. However, macro headwinds, continued investments and increasing competition from Tencent Holdings and Baidu remain the overhangs.
(You can ).
Other noteworthy reports we are featuring today include Anthem (ANTM), Activision Blizzard (NASDAQ:ATVI) and Marriott (MAR).
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, approval of new drugs and label expansion of Perjeta, Tecentriq and Alecensa bode well for Roche as stiff competition from biosimilars looms large for some of its key drugs.
Per the Zacks analyst, Apoquel and Simparica boost companion animal business for Zoetis amid competition for Revolutiion, Rimadyl, and Clavamox.
Per the Zacks analyst, plan to open a battery testing hub in China and tie-ups with other companies to develop electric vehicle technologies will aid Toyota to gain from the rising demand for EVs.
Per the Zacks analyst, Activision's top-line growth is driven by well-known franchises such as Call of Duty, Overwatch & Candy Crush.
While the impending Andeavor buy will transform Marathon Petroleum (NYSE:MPC) into the top U.S. refiner in terms of capacity, the Zacks analyst is worried over lower product margin in its Speedway unit.
The Zacks analyst believes that strong RevPAR growth in most of the markets worldwide will continue to boost Marriott's performance.
Per the Zacks analyst, solid medical membership and effective capital deployment pave way for long-term growth.
Per the Zacks analyst, approval of new drugs and label expansion of Perjeta, Tecentriq and Alecensa bode well for Roche as stiff competition from biosimilars looms large for some of its key drugs.
Per the Zacks analyst, Apoquel and Simparica boost companion animal business for Zoetis amid competition for Revolutiion, Rimadyl, and Clavamox.
Per the Zacks analyst, plan to open a battery testing hub in China and tie-ups with other companies to develop electric vehicle technologies will aid Toyota to gain from the rising demand for EVs.
Per the Zacks analyst, Activision's top-line growth is driven by well-known franchises such as Call of Duty, Overwatch & Candy Crush.
While the impending Andeavor buy will transform Marathon Petroleum (NYSE:MPC) into the top U.S. refiner in terms of capacity, the Zacks analyst is worried over lower product margin in its Speedway unit.
The Zacks analyst believes that strong RevPAR growth in most of the markets worldwide will continue to boost Marriott's performance.
Per the Zacks analyst, solid medical membership and effective capital deployment pave way for long-term growth.
New Upgrades/h6
Per the Zacks analyst, Regal Beloit focuses on prudent investment decisions for a disciplined capital allocation, strong & flexible balance sheet and cash flow enhancement to support dividend growth.
Per the Zacks analyst, strong portfolio post Synergy Health addition helped STERIS to fortify its global presence in sterilization service space. Solid financials have helped it to go for new buyouts.
Per the Zacks analyst, an active acquisition strategy in 2017 has aided the company's inorganic growth, divestiture of AMR business will further help to focus on core business areas.
Per the Zacks analyst, Regal Beloit focuses on prudent investment decisions for a disciplined capital allocation, strong & flexible balance sheet and cash flow enhancement to support dividend growth.
Per the Zacks analyst, strong portfolio post Synergy Health addition helped STERIS to fortify its global presence in sterilization service space. Solid financials have helped it to go for new buyouts.
Per the Zacks analyst, an active acquisition strategy in 2017 has aided the company's inorganic growth, divestiture of AMR business will further help to focus on core business areas.
New Downgrades/h6
Per the Zacks analyst, rising costs, lower profits from acquired businesses, reduced volumes, unfavorable mix and ongoing restructuring moves might continue to dent Middleby's near-term profitability.
News Corporation is grappling with soft print advertising demand, mainly in Australia and the U.S. Per the Zacks analyst, the company needs to ramp up businesses in digital space to offset the same.
Per the Zacks analyst, increasing mix of subscription-based licenses is expected to negatively impact CA's fiscal 2019 top-line growth. Lower renewal rate also remains a concern.
Per the Zacks analyst, rising costs, lower profits from acquired businesses, reduced volumes, unfavorable mix and ongoing restructuring moves might continue to dent Middleby's near-term profitability.
News Corporation is grappling with soft print advertising demand, mainly in Australia and the U.S. Per the Zacks analyst, the company needs to ramp up businesses in digital space to offset the same.
Per the Zacks analyst, increasing mix of subscription-based licenses is expected to negatively impact CA's fiscal 2019 top-line growth. Lower renewal rate also remains a concern.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.